Dmd (original) (raw)
Latest News for: dmd
Obituary: N. Rich Lindquist DMD
The Brunswick Times Record 12 Jun 2026
DMD Systems Recovery Named to CRN® Solution Provider 500 as Data Center Expansion Increases Demand for Secure IT Asset Disposition
PR Newswire 11 Jun 2026
TEMPE, Ariz., June 11, 2026 /PRNewswire/ -- DMD Systems Recovery, LLC (DMD), a Reuse First® IT asset disposition (ITAD) services provider, has been named to the 2026 CRN® Solution Provider 500 for the fourth consecutive year.
Opening Remarks by Deputy Managing Director Kenji Okamura at the Eleventh Tokyo Fiscal Forum
International Monetary Fund 10 Jun 2026
Opening Remarks by Deputy Managing Director Kenji Okamura at the Eleventh Tokyo Fiscal Forum ....
Obituary: N. Rich Lindquist, DMD
The Brunswick Times Record 09 Jun 2026
SIU School of Dental Medicine Graduates 57 Dentists; Dean Emeritus Bruce Rotter, DMD, MS Gives Keynote (Southern Illinois University System - Edwardsville)
Public Technologies 08 Jun 2026
Cameron Altadonna, DMD, '26, hooded by his father, Darren Altadonna, DMD, '95 Samuel Donavon, DMD, '26, hooded by his brother, James Donavon, DMD, '23 Matilyn Harsy, DMD, '26, hooded by her sister, ...
Michael L. Hughes, DMD
Calhoun Times 31 May 2026
Michael L. Hughes, DMD, 83, passed away May 25, 2026. He was predeceased by his parents, Hatton L. and Ora Mae Hughes, of Gadsden, AL. He is survived by his wife of 47 years, Karen Kramer Hughes; daughter, Heather Hughes ....
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD) (Dyne Therapeutics Inc)
Public Technologies 26 May 2026
Food and Drug Administration (FDA) for zeleciment rostudirsen (z-rostudirsen, also known as DYNE-251) 20 mg/kg Q4W for the treatment of individuals with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping.
HelloNation Examines Dental Implants And Dentures With Dental Implant Professional Dr. Steven Dodson, DMD
PR Newswire 21 May 2026
Steven Dodson, DMD, of Altoona Dentistry Implants Dentures. Continue Reading. Dr. Steven Dodson, General Dentist Speed Speed ... Steven Dodson, DMD, Dental Implant Professional of Altoona, Pennsylvania, in HelloNation ... SOURCE HelloNation. 21% ... Request a Demo. .
Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the ...
Business Wire 14 May 2026
The new data show that treatment with PBGENE-DMD in early-juvenile mice .
GEMMABio Unveils Duchenne Muscular Dystrophy (DMD) Program and Presents Preclinical Data for Next‑Generation Gene Therapies for DMD and Spinal Muscular Atrophy Type 1 (SMA1) at the ASGCT 2026 Annual Meeting
PR Newswire 14 May 2026
Juliette Hordeaux, DVM, PhD, DECVP, Chief Scientific Officer at GEMMABio, will present the DMD data today at 8.15 a.m ... Key Highlights from the DMD Presentation at ASGCT include ... DMD is the most common type of muscular dystrophy worldwide.
HelloNation Highlights What to Expect During an Orthodontic Consultation, Featuring Expert Orthodontist Dr. Michelle Mathieson, DMD, MSD
PR Newswire 06 May 2026
The article outlines how digital scans, bite check evaluations, and clear treatment options guide personalized orthodontic care ... Continue Reading. Dr. Michelle Mathieson, DMD, MSD - Owner & Orthodontist, Harmony Orthodontics Speed Speed ... 21% ... .
Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study
Business Wire 29 Apr 2026
... of the first clinical trial site and the opening of patient screening and enrollment for PBGENE-DMD.
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged ...
Nasdaq Globe Newswire 27 Apr 2026
... treatment of patients with Duchenne muscular dystrophy (DMD) from 2 years of age.
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU (Santhera Pharmaceuticals Holding AG)
Public Technologies 27 Apr 2026
https.//www.santhera.com Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU ... AGAMREE for the treatment of DMD is approved in the U.S.
Family Dentistry Expert John W. Barone, DMD of North Attleborough Discusses Cosmetic Dentistry as Precision ...
The Eagle-Tribune 20 Apr 2026
John W. Barone of North Attleborough .